Composition of the Intestinal Microbiome in Patients With Recurrent Spontaneous Abortions.
NCT ID: NCT07246486
Last Updated: 2025-11-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
60 participants
OBSERVATIONAL
2020-11-01
2023-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study will be investigate if there is a connection between the composition of the intestinal microbiome and the occurence of recurrent spontaneous abortions.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Better Contraceptive Choices: Immediate or Delayed Insertion of IUC After Second Trimester Abortion
NCT00877344
Prolonged Treatment for Infected Abortion After Hospital Discharge.
NCT00376493
Post Abortion IUD & Recurrent Abortion 2001-2004
NCT00965770
Histopathological Evaluation of Product of Conception in Sporadic and Recurrent Abortions
NCT04326595
To Compare the Strategies of Universal Antibiotic Prophylaxis Versus Screen-and-treat in Reducing Infective Complications and Re-infection in Women Who Undergo Termination of Pregnancy
NCT01842100
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In this study 60 non-pregnant women will be included. 20 women with at least one complication-free pregnancy and no abortions or premature birth in medical history and 40 non-pregnant women with two or three recurrent spontaneous abortions in medical history.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
2 spontaneous abortions
non-pregnant women with two spontaneous abortions in medical history
No interventions assigned to this group
3 spontaneos abortions
non-pregnant women with two spontaneous abortions in medical history
No interventions assigned to this group
controle-group
non-pregnant women with at least one complication-free pregnancy with no premature birth or late abortion in medical history
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 2 or 3 spontaneous abortions in medical history
Exclusion Criteria
* Current pregnancy
* Immunosuppressive therapy
* Antibiotic therapy up to four weeks before admission
* Acute infection
* Orale intake of probiotics up to four weeks before admission
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
German Center for Infection Research
OTHER
Dr. Natascha Köstlin-Gille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Natascha Köstlin-Gille
PD Dr. med. Natascha Köstlin-Gille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Tübingen
Tübingen, Baden-Wurttemberg, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
730/2020BO2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.